Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen-Releasing Nanosheet in Gastric Cancer Chemotherapy in Mice

Acid‐Responsive H<sub>2</sub>‐Releasing 2D MgB<sub>2</sub> Nanosheet for Therapeutic Synergy and Side Effect Attenuation of Gastric Cancer Chemotherapy

Research hubs: Digestive System · Cardiovascular System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Acid‐Responsive H<sub>2</sub>‐Releasing 2D MgB<sub>2</sub> Nanosheet for Therapeutic Synergy and Side Effect Attenuation of Gastric Cancer Chemotherapy
Evidence type
Animal study (mouse)
Authors
Mingjian Fan, Yanyuan Wen, Dien Ye, Zhaokui Jin, Penghe Zhao, Danyang Chen, Xifeng Lu, Qianjun He
Journal
Advanced Healthcare Materials
Year
2019
Study Type
Mouse
Delivery
Gas (Sustained Release)
Outcome
Positive
Peer Reviewed
Yes
Cited by
90 (OpenAlex, as of November 2026)
Country
China

TL;DR

Scientists have created a new pill that releases hydrogen in the stomach to help reduce the harmful side effects of chemotherapy and improve its effectiveness against gastric cancer.

Key Finding

In mice, combining a hydrogen-releasing pill with doxorubicin chemotherapy significantly prolonged survival and reduced chemotherapy side effects compared to chemotherapy alone.

Summary

Researchers developed a new pill containing magnesium boride nanoparticles that release hydrogen gas in the stomach. In mice with gastric cancer, combining this hydrogen-releasing pill with the chemotherapy drug doxorubicin improved survival and reduced the toxic side effects that normally occur with chemotherapy alone. The researchers believe hydrogen works by interfering with cancer cells' energy production while leaving normal cells unharmed.

Practical Takeaway

This is early-stage research in mice only, so it cannot yet predict effects in humans. The concept of using hydrogen to enhance chemotherapy while reducing side effects is promising, but much more research—including human trials—would be needed before any practical application. The specific nanoparticle delivery system tested here is not currently available as a consumer product.

Abstract (excerpt)

AbstractThe hydrogen molecule is recognized as a high potential to attenuate toxic side effects of chemotherapy and also enhance chemotherapeutic efficacy, and the development of a novel hydrogen‐generating prodrug for facile, safe, and efficient hydrogen delivery is vitally important for combined…

Read the full abstract on PubMed